Navigation Links
Identified 2 new genes involved in the more aggressive prostate cancer
Date:5/13/2014

A study by the Columbia University Nova York, in collaboration with the Catalan Institute of Oncology , Belvitge Biomedical Research Institute (ICO-IDIBELL) has identified two new genes that lead to more aggressive forms of prostate cancer. The work done by Alvaro Aytes under the direction of Cory Abate-Shen , director of the Herbert Irving Comprehensive Cancer Center of the Columbia University, has been published in the latest issue of Cancer Cell.

Prostate cancer

Prostate cancer is the most common in men in Europe( accounts for 20% of all male tumors). The incidence is about 60 new cases per 100,000 inhabitants per year.

A tumor closely associated with old age, and most cases is diagnosed between 70 and 80 years. The progressive aging of the population has made it one of the tumors that has increased in recent decades. Survival is quite high: according to Oncology Master Plan, 84 % of patients are alive five years after diagnosis.

Identify high-risk patients

In a significant proportion of patients the prostate tumor has a not very aggressive behavior, which does not compromise the health and quality of life of the affected. Also, being a tumor that usually occurs in old age, often the person dies with the tumor but not as a result of this.

It is therefore necessary to develop tools to predict which prostate tumors are clinically relevant and potentially lethal. This would open the door to customize treatments and avoid certain therapies and , therefore, avoid side effects to patients that do not need it, further reducing healthcare costs.

Two new genes in the spotlight

The study published in Cancer Cell identified two genes, the FOXM1 and CENPF, if they are abnormally activated simultaneously, lead to more aggressive and life threatening forms of prostate cancer .

A new feature of the study is that computer algorithms were used to generate netw
'/>"/>

Contact: Arantxa Mena
amena@idibell.cat
0034-932-607-282
IDIBELL-Bellvitge Biomedical Research Institute
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Predictors identified for rehospitalization among post-acute stroke patients
2. 2 repressor genes identified as essential for placental development
3. Possible new cancer treatment identified
4. Gene Behind Psoriasis Identified, Researchers Say
5. A microRNA prognostic marker identified in acute leukemia
6. Early biomarker for pancreatic cancer identified
7. The cells petrol pump is finally identified
8. Mutations in JAK3 gene identified in subtype of lymphoma provide potential drug target
9. New cerebellar ataxia gene identified in dogs
10. Misidentified and contaminated cell lines lead to faulty cancer science
11. Germ Culprits in Moldy, Water-Damaged Buildings Identified
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Identified 2 new genes involved in the more aggressive prostate cancer
(Date:9/2/2014)... Today, Therapy Changes released ... Me?” The guide outlines common questions an individual may ... to common types of groups an individual can attend. ... the interventions of the therapist, but also from observing ... members,” says Rochelle Perper, Ph.D. and founder of Therapy ...
(Date:9/2/2014)... Friendship Village of Schaumburg is proud ... a contemporary marketing presence and visually solidifies the ... Friendship Senior Options,” said Stephen A. Yenchek, president ... the logo, we are making sure that our ... their families.” , Friendship Village is a retirement ...
(Date:9/2/2014)... 2, 2014 (HealthDay News) -- Complications are rare ... reconstruction, a new study indicates. However, the ... associated with a slightly higher risk for certain ... included more than 18,000 breast cancer patients who ... mastectomy with breast reconstruction and were followed for ...
(Date:9/2/2014)... return to the emergency department within a few days of ... symptoms and have lost trust in other parts of the ... published online today in Annals of Emergency Medicine ... ). , "When asked why they did not ... symptoms were too severe to wait until their scheduled appointment ...
(Date:9/2/2014)... Sept. 2, 2014 (HealthDay News) -- Two new studies ... suggests that 6-year-olds who were breast-fed have a lower ... bottle-fed infants, while the other finds a similar trend ... the "many benefits of breast-feeding in the immediate newborn ... Hill Hospital in New York City. She was not ...
Breaking Medicine News(10 mins):Health News:Friendship Village of Schaumburg In Illinois Announces New Logo 2Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... cancer-prevention gene in the response to drug treatment for childhood ... known as the guardian of the genome, is known for ... gene are associated with a high incidence of cancer due ... tumours. , In childhood cancers such as neuroblastoma, p53 mutations ...
... tuning out distractions can be learned , MONDAY, Nov. ... a person,s brain is organized, says a U.S. study that ... training. , All the participants were between the ages of ... than 10 years experience as a band or orchestra director ...
... FDA says clotting drug poses increased death risk, while company ... (HealthDay News) -- Bayer AG suspended worldwide sales of Trasylol, ... on Monday following a request from the U.S. Food and ... for safety reasons. , The FDA cannot identify a patient ...
... HONG KONG, Nov. 5 Mass Financial Corp. ... a lawsuit in the Supreme Court of,British Columbia, ... for breach of contract and contract interference. In ... Michael Smith, President of MASS said the ...
... Inc. (Nasdaq: ALTH ) today reported financial results for ... 30, 2007, the,Company reported a net loss of $9.3 million, ... $8.1 million, or ($0.15) per share, for the third,quarter of ... Company,reported a net loss of $28.1 million, or ($0.43) per ...
... 5 Hooper Holmes,Inc. (AMEX: HH ) announced ... after-market on Thursday, November 8, 2007. The Company,will host ... 11:00 a.m.,Eastern Time. To participate in the third ... Hooper Holmes. A live web cast,will be hosted on ...
Cached Medicine News:Health News:Training, Experience Can Change How Brains Work 2Health News:Trasylol Pulled From Worldwide Market 2Health News:Trasylol Pulled From Worldwide Market 3Health News:Trasylol Pulled From Worldwide Market 4Health News:Mass Financial Corp. Launches Lawsuit Against Elekta AB, Seeks Substantial Damages 2Health News:Allos Therapeutics Reports Third Quarter 2007 Financial Results 2Health News:Allos Therapeutics Reports Third Quarter 2007 Financial Results 3Health News:Allos Therapeutics Reports Third Quarter 2007 Financial Results 4Health News:Allos Therapeutics Reports Third Quarter 2007 Financial Results 5Health News:Allos Therapeutics Reports Third Quarter 2007 Financial Results 6Health News:Allos Therapeutics Reports Third Quarter 2007 Financial Results 7Health News:Hooper Holmes Announces Third Quarter Earnings Release Date and Conference Call Information 2
(Date:9/2/2014)... -- Particle Sciences, the leading CDMO for drug eluting ... manufacturing capabilities with the addition of a new 18mm ... Associate Director Clinical Production, "The company has been expanding ... equipment and staff across the board, all aimed at ... 6000ft 2 of operating cleanroom and cGMP warehouse ...
(Date:9/2/2014)... 2014  Edison Nation Medical, the premier healthcare ... American Association for Respiratory Care ( AARC ), ... Edison Nation Medical, which brings 12+ years experience ... their innovation ideas, will work with AARC to ... 50,000 respiratory therapists in bringing their product innovation ...
(Date:9/2/2014)... 2, 2014  PANTHERx Specialty Pharmacy announced today ... from URAC, a Washington, DC ... standards for the health care industry. ... The URAC accreditation process demonstrates a commitment to ... improve business processes through benchmarking organizations against nationally ...
Breaking Medicine Technology:Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 3PANTHERx Specialty Pharmacy Applying for URAC Specialty Pharmacy Accreditation 2
... N.J., Oct. 12 Schering-Plough Corporation (NYSE: SGP ) ... the 2009 third quarter on Thursday, Oct. 22, 2009. ... Schering-Plough will conduct a conference call to review results for ... CEO, and other members of management will host the conference ...
... , ANN ARBOR, Mich., Oct. 12 The University ... (®) from Thomson Reuters to provide physicians, nurses, and ... electronic drug dosing, interaction checking, and reference information. ... 575-bed academic medical center that specializes in heart disease, ...
Cached Medicine Technology:Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings 2University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 2University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety 3
... Biventricular Stimulation Device is ... and two ventricular) multi-chamber ... the heart in a ... to promote resynchronization and ...
... system automatically presents diagnostic information ... pacemaker that is easy to ... The automatic Initial Interrogation Report ... clinicians answer their most critical ...
... completely automatic pacemaker, EnPulse offers ... sophisticated yet simple to use. ... of diagnostic tests on a ... This allows more time to ...
The INSIGNIA® pacing systems allow the physician to provide customized adaptive-rate pacing therapy to meet individual patient needs....
Medicine Products: